USA: Findings from the nonrandomized STUN-AF study suggest that, among patients undergoing concomitant pulsed-field ablation ...

Boston Scientific Corporation (NYSE:BSX) is one of the best stocks to invest in according to Two Sigma Advisors with huge ...

THE ANNUAL world-leading course in interventional cardiology, EuroPCR, welcomed 12,147 participants to Paris, France, for a dynamic ...

The approach should be considered to prevent leaks, which have been tied to increased stroke risks, Vivek Reddy says.

My daughter, who’s 44 years old, was recently diagnosed with rectal cancer. It’s stage III and contained. She has no cancer in her liver, lymph nodes, rectum ...

International groups agreed on a second universal definition of heart failure, which moves away from rigid ejection fraction ...

Boston Scientific Corporation (NYSE:BSX) is one of the most promising future stocks to buy right now. Stifel cut the price ...

Edwards Lifesciences secures FDA clearance for its ECLIPTIS Left Atrial Appendage Exclusion System, entering a competitive ...

Edwards Lifesciences is expected to introduce the new device to surgical heart valve customers this year in a “measured, ...

The persistent peridevice leaks in percutaneous left atrial appendage (LAA) closure may be addressed by applying pulsed field ...

Edwards Lifesciences (NYSE:EW) has earned FDA 510(k) clearance for Ecliptis, its left atrial appendage (LAA) exclusion system. According to the FDA 510(k) database, the agency cleared the clip device ...

Introduction: The hybrid strategy, defined as left atrial appendage closure (LAAC) followed by long‑term anticoagulation, may be considered in patients with thromboembolic events or left atrial ...